BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 78653)

  • 1. Human prostatic carcinoma: significant differences in its androgen binding and metabolism compared to the human benign prostatic hypertrophy.
    Krieg M; Grobe I; Voight KD; Altenähr E; Klosterhalfen H
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):397-407. PubMed ID: 78653
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy.
    Krieg M; Bartsch W; Herzer S; Becker H; Voigt KD
    Acta Endocrinol (Copenh); 1977 Sep; 86(1):200-15. PubMed ID: 71838
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
    Krieg M; Bartsch W; Janssen W; Voigt KD
    J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
    Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
    [No Abstract]   [Full Text] [Related]  

  • 5. The baboon prostate as a model for steroid hormone receptors in the human gland.
    Karr JP; Kirdani RY; Murphy GP; Sandberg AA
    Prog Clin Biol Res; 1979; 33():165-79. PubMed ID: 119228
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgen binding and metabolism in the human prostate.
    Attramadal A; Tveter KJ; Weddington SC; Djöseland O; Naess O; Hansson V; Torgersen O
    Vitam Horm; 1975; 33():247-64. PubMed ID: 59460
    [No Abstract]   [Full Text] [Related]  

  • 7. Protamine sulfate precipitation of androgen receptors in cytosols of human benign and malignant prostatic tumors.
    Mobbs BG; Johnson IE; Connolly JG
    Prog Clin Biol Res; 1979; 33():13-32. PubMed ID: 93749
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism and action of steroid hormones on human benign prostatic hyperplasia and prostatic carcinoma grown in organ culture.
    Lasnitzki I
    J Steroid Biochem; 1979 Jul; 11(1B):625-30. PubMed ID: 90755
    [No Abstract]   [Full Text] [Related]  

  • 9. Histochemical detection of steroid hormone receptors in the human prostate.
    Pertschuk LP; Zava DT; Tobin EH; Brigati DJ; Gaetjens E; Macchia RJ; Wise GJ; Wax HS; Kim DS
    Prog Clin Biol Res; 1979; 33():113-32. PubMed ID: 93748
    [No Abstract]   [Full Text] [Related]  

  • 10. In-vitro studies on testosterone and 5alpha-dihydrotestosterone binding in benign prostatic hypertrophy (BPH).
    Steins P; Hollmann HJ; Schmidt H; Voigt KD
    Acta Endocrinol Suppl (Copenh); 1973; 173():69. PubMed ID: 4125280
    [No Abstract]   [Full Text] [Related]  

  • 11. [Androgen, progestin and estrogen receptors in the normal human prostate and in pathology].
    Gerasimova TsI; Smirnov AN; Rozen VB; Buniatian AF; Bol'shakova TD
    Sov Med; 1984; (6):32-6. PubMed ID: 6205454
    [No Abstract]   [Full Text] [Related]  

  • 12. Androgen receptors in prostate cancer.
    White RD; Olsson CA
    Urology; 1981 Apr; 17(4 Suppl):24-6. PubMed ID: 7193939
    [No Abstract]   [Full Text] [Related]  

  • 13. Androgen metabolism in patients with benign prostatic hypertrophy.
    Voigt KD; Horst HJ; Krieg M
    Vitam Horm; 1975; 33():417-38. PubMed ID: 59462
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of androgen and estrogen receptors in human prostatic carcinoma and hyperplasia by fluorescence microscopy.
    Pertschuk LP; Zava DT; Gaetjens E; Macchia RJ; Brigati DJ; Kim DS
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):427-30. PubMed ID: 569892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor proteins for androgens in prostatic disease.
    Ghanadian R; Auf G; Chisholm GD; O'Donoghue EP
    Br J Urol; 1978 Dec; 50(7):567-9. PubMed ID: 88985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
    de Jong FH; Oishi K; Hayes RB; Bogdanowicz JF; Raatgever JW; van der Maas PJ; Yoshida O; Schroeder FH
    Cancer Res; 1991 Jul; 51(13):3445-50. PubMed ID: 1711411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.
    Mobbs BG; Johnson IE; Connolly JG; Clark AF
    J Steroid Biochem; 1978 Apr; 9(4):289-301. PubMed ID: 77938
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex steroid hormone receptors and human prostatic hyperplasia and carcinoma.
    Robel P
    Ann Clin Res; 1980 Oct; 12(5):216-22. PubMed ID: 6165318
    [No Abstract]   [Full Text] [Related]  

  • 19. Androgen receptors in benign and malignant prostatic tissue.
    Lakey WH; Bruchovsky N; Callaway T; Comeau T; Lieskovsky G; Rennie P; Shnitka T; Wilkin P
    Trans Am Assoc Genitourin Surg; 1979; 71():19-22. PubMed ID: 94714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dihydrotestosterone-binding characteristics in human prostatic adenoma].
    Gerasimova TsI; Smirnov AN; Buniatian AF
    Probl Endokrinol (Mosk); 1982; 28(5):37-42. PubMed ID: 6183657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.